Cambridge Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.63K | Sell |
10
-147
| -94% | -$141K | ﹤0.01% | 579 |
|
|
2023
Q4 | $138K | Sell |
157
-11
| -7% | -$9.66K | 0.01% | 309 |
|
|
2023
Q3 | $138K | Buy |
168
+11
| +7% | +$9.05K | 0.01% | 308 |
|
|
2023
Q2 | $113K | Hold |
157
| – | – | 0.01% | 342 |
|
|
2023
Q1 | $129K | Hold |
157
| – | – | 0.01% | 326 |
|
|
2022
Q4 | $113K | Buy |
157
+4
| +3% | +$2.88K | 0.01% | 346 |
|
|
2022
Q3 | $105K | Hold |
153
| – | – | 0.01% | 355 |
|
|
2022
Q2 | $91K | Hold |
153
| – | – | ﹤0.01% | 408 |
|
|
2022
Q1 | $107K | Sell |
153
-14
| -8% | -$9.79K | ﹤0.01% | 417 |
|
|
2021
Q4 | $106K | Buy |
+167
| New | +$106K | ﹤0.01% | 414 |
|